These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10440474)

  • 1. Psychotic depression occurring after stopping interferon-alpha.
    Prior TI; Chue PS
    J Clin Psychopharmacol; 1999 Aug; 19(4):385-6. PubMed ID: 10440474
    [No Abstract]   [Full Text] [Related]  

  • 2. The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depression.
    Zincke MT; Kurani A; Istafanous R; Kellner C
    J ECT; 2007 Dec; 23(4):291-2. PubMed ID: 18090708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychiatric side effects during adjuvant therapy with interferon-alphain patients with malignant melanoma. Clinical evaluation as well as diagnostic and therapeutic possibilities].
    Schäfer M; Messer T; Wegner U; Schmid-Wendtner MH; Volkenandt M
    Hautarzt; 1999 Sep; 50(9):654-8. PubMed ID: 10501682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypotension following inadvertent intravenous administration of interferon alfa-2a.
    Hanson DS; Leggette CT
    Ann Pharmacother; 1997 Mar; 31(3):371-2. PubMed ID: 9066950
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon adjuvant therapy of melanoma.
    Kirkwood JM; Wazer D; Rosenstein M
    Cancer; 1997 May; 79(9):1843-6. PubMed ID: 9129006
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudodementia masking substance abuse and depression.
    Good WV; Dubovsky SL
    Psychosomatics; 1982 Jun; 23(6):652-7. PubMed ID: 7122798
    [No Abstract]   [Full Text] [Related]  

  • 7. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
    Johnson DM; Hayat SQ; Burton GV
    J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of adjuvant interferon study in WHO melanoma programme.
    Cascinelli N; Bufalino R; Morabito A; Mackie R
    Lancet; 1994 Apr; 343(8902):913-4. PubMed ID: 7908370
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroid-induced depressive psychosis responsive to electroconvulsive therapy.
    Sutor B; Wells LA; Rummans TA
    Convuls Ther; 1996 Jun; 12(2):104-7. PubMed ID: 8744170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy of melanoma: at what cost?
    Spitler LE
    J Clin Oncol; 2001 Feb; 19(4):1226-8. PubMed ID: 11181688
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant interferon alfa-2b for high-risk melanoma.
    Retsas S
    J Clin Oncol; 1996 Jun; 14(6):1968-9. PubMed ID: 8656272
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].
    Bernengo MG; Doveil GC; Appino A; Sertoli MR; Ardizzoni A; Vidili MG
    G Ital Dermatol Venereol; 1988 Apr; 123(4):185-8. PubMed ID: 3182009
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic treatment of depression induced by interferon-alpha.
    Hauser P; Soler R; Reed S; Kane R; Gulati M; Khosla J; Kling MA; Valentine AD; Meyers CA
    Psychosomatics; 2000; 41(5):439-41. PubMed ID: 11015632
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccine therapy for malignant melanoma.
    Morton DL; Barth A
    CA Cancer J Clin; 1996; 46(4):225-44. PubMed ID: 8673695
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammatory reaction presages response in melanoma skin lesions during i.m. rIFN alpha-2a-based treatment.
    Bracarda S; Roila F; Basurto C; Tonato M
    Ann Oncol; 1990 Sep; 1(5):381. PubMed ID: 2148107
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma.
    Lohmann CP; Kroher G; Bogenrieder T; Spiegel D; Preuner J
    Lancet; 1999 Apr; 353(9161):1326. PubMed ID: 10218534
    [No Abstract]   [Full Text] [Related]  

  • 17. Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders.
    Navinés R; Gómez-Gil E; Puig S; Baeza I; De Pablo J; Martín-Santos R
    Eur J Dermatol; 2009; 19(6):611-5. PubMed ID: 19709980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma.
    Grob JJ; Dreno B; de la Salmonière P; Delaunay M; Cupissol D; Guillot B; Souteyrand P; Sassolas B; Cesarini JP; Lionnet S; Lok C; Chastang C; Bonerandi JJ
    Lancet; 1998 Jun; 351(9120):1905-10. PubMed ID: 9654256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus therapy of human cancers.
    Sinkovics JG; Horvath JC
    Melanoma Res; 2003 Aug; 13(4):431-2. PubMed ID: 12883372
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.